CH Biotech R&D Co (TPE:6534) OCF Margin %: 69.20% (As of Dec. 2025) — 103% Above Median


TPE:6534 CH Biotech R&D Co Ltd TPE:6534
84 GF Score
Price NT$90.10
GF Value NT$100.55
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is CH Biotech R&D Co OCF Margin %?

CH Biotech R&D Co TPE:6534 +0.33% 84 OCF Margin % is 69.20% as of Dec. 2025, which is 103% above its 10-year median of 34.04. GuruFocus rates TPE:6534 with a GF Score™ of 84/100 and a GF Value™ of NT$100.55 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 248 Agriculture companies, CH Biotech R&D Co ranks better than 94.35% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. CH Biotech R&D Co's Cash Flow from Operations for the three months ended in Dec. 2025 was NT$227 Mil. CH Biotech R&D Co's Revenue for the three months ended in Dec. 2025 was NT$328 Mil. Therefore, CH Biotech R&D Co's OCF Margin % for the quarter that ended in Dec. 2025 was 69.20%.

As of today, CH Biotech R&D Co's current OCF Yield % is 6.49%.

The historical rank and industry rank for CH Biotech R&D Co's OCF Margin % or its related term are showing as below:

TPE:6534' s OCF Margin % Range Over the Past 10 Years
Min: 25.96   Med: 34.04   Max: 49.16
Current: 32.38


During the past 13 years, the highest OCF Margin % of CH Biotech R&D Co was 49.16%. The lowest was 25.96%. And the median was 34.04%.

TPE:6534's OCF Margin % is ranked better than
94.35% of 248 companies
in the Agriculture industry
Industry Median: 4.83 vs TPE:6534: 32.38


CH Biotech R&D Co OCF Margin % Related Terms


CH Biotech R&D Co OCF Margin % Historical Data

* Premium members only.

The historical data trend for CH Biotech R&D Co's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CH Biotech R&D Co OCF Margin % Chart

CH Biotech R&D Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.96 48.74 43.51 32.92 32.38

CH Biotech R&D Co Quarterly Data
Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.39 24.45 62.51 -50.65 69.20

TPE:6534 vs CTVA, CF, MOS: OCF Margin % Comparison

For the Agricultural Inputs subindustry, CH Biotech R&D Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CH Biotech R&D Co OCF Margin % vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, CH Biotech R&D Co's OCF Margin % distribution charts can be found below:

* The bar in red indicates where CH Biotech R&D Co's OCF Margin % falls into.


TPE:6534
84GF Score
CH Biotech R&D Co Ltd TPE:6534
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CH Biotech R&D Co OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

CH Biotech R&D Co's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=589.023/1819.183
=32.38 %

CH Biotech R&D Co's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=227.221/328.376
=69.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 69.20% mean?
CH Biotech R&D Co (TPE:6534) has a OCF Margin % of 69.20% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on CH Biotech R&D Co and its competitors. This is 103% above median its historical median of 34.04. Over the past decade, CH Biotech R&D Co's OCF Margin % has ranged from 25.96 to 49.16. According to the industry distribution chart, CH Biotech R&D Co ranks #14 out of 248 companies in the Agriculture industry, placing it in the top 5.6%.
Is CH Biotech R&D Co's OCF Margin % too high?
CH Biotech R&D Co's current OCF Margin % of 69.20% is 103% above median its 10-year median of 34.04. Over the past 10 years, this metric has ranged from a low of 25.96 to a high of 49.16. The Agriculture industry median OCF Margin % is 4.83. CH Biotech R&D Co's value of 69.20% is 1332.7% above this industry median. Based on the distribution chart, CH Biotech R&D Co ranks #14 out of 248 companies in the Agriculture industry, which is in the top quartile — a strong position relative to peers. Overall, CH Biotech R&D Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CH Biotech R&D Co's OCF Margin % compare to CTVA and CF?
According to the Agriculture industry distribution chart, CH Biotech R&D Co ranks #14 out of 248 companies for OCF Margin %. This places CH Biotech R&D Co in the top 6% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 4.83. CH Biotech R&D Co's value of 69.20% is 1332.7% above this benchmark. Historically, CH Biotech R&D Co's own OCF Margin % has ranged from 25.96 to 49.16 over the past decade. While the company's 10-year median is 34.04 vs. the industry median of 4.83, CH Biotech R&D Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for an Agriculture company?
The median OCF Margin % among Agriculture companies is 4.83, based on 248 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CH Biotech R&D Co's current OCF Margin % of 69.20% is 1332.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on CH Biotech R&D Co and its competitors. For the Agriculture industry, the median OCF Margin % is 4.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CH Biotech R&D Co's current OCF Margin % is 69.20%, which is 103% above median its own 10-year median of 34.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CH Biotech R&D Co stock overvalued right now?
Based on GuruFocus' analysis, CH Biotech R&D Co (TPE:6534) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$100.55, compared to a current price of NT$90.10 — trading 10.4% below its estimated fair value. The current OCF Margin % is 69.20%, which is 103% above median its 10-year median of 34.04 and 1332.7% above the Agriculture industry median of 4.83. CH Biotech R&D Co's overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For CH Biotech R&D Co (TPE:6534), the current OCF Margin % is 69.20% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CH Biotech R&D Co (TPE:6534) Overvalued in 2026?

Based on GuruFocus' analysis, CH Biotech R&D Co stock appears to be undervalued. The current stock price of NT$90.10 is trading 10.4% below its estimated GF Value™ of NT$100.55. GuruFocus considers CH Biotech R&D Co to be Modestly Undervalued.

Key valuation signals for TPE:6534:

  • OCF Margin %: 69.20% (103% above median its 10-year median of 34.04)
  • GF Value™: NT$100.55 vs. price of NT$90.10 (10.4% below fair value)
  • GF Score™: 84/100 with 1 warning sign
  • Industry Position: 1332.7% above the Agriculture median (#14 of 248)

No single metric tells the full story. See the TPE:6534 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CH Biotech R&D Co Business Description

Address No. 89, Wenxian Road, Nantou County, Nantou City, TWN, 540001
CH Biotech R&D Co Ltd is a Taiwan-based company engaged in the manufacture and sales of fertilizer, as well as providing biotechnology services. It is engaged in the research, development, manufacturing, and sales of proprietary plant growth regulators and specialty micronutrient fertilizers. It offers NutriSync 3D plant growers in the form of boron and molybdenum, NutriSync D liquid formulation for dicot crops, CHB-HS for reducing carbon emissions in crop production, CHB-BB2, fruit quality enhancers, and other related products. The company has one reportable segment, Agricultural Biotechnology. Geographically, it derives maximum revenue from the United States, and the rest from other countries.
84GF Score

Get the complete analysis for TPE:6534

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$90.10
Price
NT$100.55
GF Value